Gsk (GSK) Gross Profit (2009 - 2026)

Gsk (GSK) has 18 years of Gross Profit data on file, last reported at $16.0 billion in Q3 2026.

• For the quarter ending Q3 2026, Gross Profit changed N/A year-over-year to $16.0 billion; the trailing twelve-month figure through Sep 2026 stood at $47.1 billion (changed N/A YoY), and the FY2025 full-year result was $31.5 billion, up 10.22% from the prior year.
• Gross Profit was $16.0 billion for Q3 2026 at Gsk, up from $8.2 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $16.0 billion in Q3 2026 to a low of $6.0 billion in Q2 2022.
• A 5-year average of $8.8 billion and a median of $7.4 billion in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit increased 24.33% in 2022 and decreased 1.96% in 2024, its largest moves.
• Gsk's Gross Profit stood at $10.8 billion in 2022, then grew by 17.61% to $12.7 billion in 2023, then gained by 12.5% to $14.3 billion in 2024, then increased by 5.91% to $15.2 billion in 2025, then rose by 5.34% to $16.0 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $16.0 billion in Q3 2026, $8.2 billion in Q2 2026, and $7.8 billion in Q1 2026.